<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0"><channel><title>The Power of Persistence: From Biotech Incubator to First Product Launch</title><link>https://www.spreaker.com/podcast/the-power-of-persistence-from-biotech-incubator-to-first-product-launch--6196929</link><description><![CDATA[Welcome to "The Power of Persistence: From Biotech Incubator to First Product Launch," a three-episode podcast series featuring seasoned experts who share valuable insights and tips about bringing biotech products to market. In this series, we delve into the journey of BioLineRx, a biopharmaceutical company founded in Israel, from its inception as a biotech incubator to achieving FDA approval for its first product, motixafortide. ]]></description><atom:link href="https://www.spreaker.com/show/6196929/episodes/feed" rel="self" type="application/rss+xml"/><language>en</language><category>Business</category><copyright>Copyright Industry Dive's studioID</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/000dc72cca9f80adb9a10884b302d090.jpg</url><title>The Power of Persistence: From Biotech Incubator to First Product Launch</title><link>https://www.spreaker.com/podcast/the-power-of-persistence-from-biotech-incubator-to-first-product-launch--6196929</link></image><lastBuildDate>Tue, 18 Jun 2024 14:04:13 +0000</lastBuildDate><itunes:author>Industry Dive's studioID</itunes:author><itunes:owner><itunes:name>Industry Dive's studioID</itunes:name><itunes:email>brandstudio@industrydive.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/000dc72cca9f80adb9a10884b302d090.jpg"/><itunes:subtitle>Welcome to "The Power of Persistence: From Biotech Incubator to First Product Launch," a three-episode podcast series featuring seasoned experts who share valuable insights and tips about bringing biotech products to market. In this series, we delve...</itunes:subtitle><itunes:summary><![CDATA[Welcome to "The Power of Persistence: From Biotech Incubator to First Product Launch," a three-episode podcast series featuring seasoned experts who share valuable insights and tips about bringing biotech products to market. In this series, we delve into the journey of BioLineRx, a biopharmaceutical company founded in Israel, from its inception as a biotech incubator to achieving FDA approval for its first product, motixafortide. ]]></itunes:summary><itunes:category text="Business"/><itunes:category text="Health &amp; Fitness"><itunes:category text="Medicine"/></itunes:category><itunes:explicit>false</itunes:explicit><itunes:type>episodic</itunes:type><item><title>Optimizing the Right Team for the Right Moment</title><link>https://www.spreaker.com/episode/optimizing-the-right-team-for-the-right-moment--60277389</link><description><![CDATA[Episode two of "The Power of Persistence" delves into the vital role that people play in the success of biotech companies. Host Jennifer LW Fink is joined by Holly May, President of BioLineRx US, who shares insights on building and optimizing the right team for a biotech startup. Holly emphasizes the importance of hiring the right people, nurturing their development, and fostering a culture of growth and innovation. The episode explores the challenges of scaling up a company's team while maintaining a focus on purpose and culture.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/60277389</guid><pubDate>Wed, 12 Jun 2024 12:58:12 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/60277389/bioline_ep2_master.mp3" length="32003798" type="audio/mpeg"/><itunes:author>Industry Dive's studioID</itunes:author><itunes:subtitle>Episode two of "The Power of Persistence" delves into the vital role that people play in the success of biotech companies. Host Jennifer LW Fink is joined by Holly May, President of BioLineRx US, who shares insights on building and optimizing the...</itunes:subtitle><itunes:summary><![CDATA[Episode two of "The Power of Persistence" delves into the vital role that people play in the success of biotech companies. Host Jennifer LW Fink is joined by Holly May, President of BioLineRx US, who shares insights on building and optimizing the right team for a biotech startup. Holly emphasizes the importance of hiring the right people, nurturing their development, and fostering a culture of growth and innovation. The episode explores the challenges of scaling up a company's team while maintaining a focus on purpose and culture.]]></itunes:summary><itunes:duration>1333</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/000dc72cca9f80adb9a10884b302d090.jpg"/><itunes:season>1</itunes:season><itunes:episode>2</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>From Incubation to Laser-Focused Biotech Innovation</title><link>https://www.spreaker.com/episode/from-incubation-to-laser-focused-biotech-innovation--60277346</link><description><![CDATA[In the inaugural episode, we explore the origins of BioLineRx and its transformation from a biotech incubator to a fully-fledged biotech company. Joined by Phil Serlin, CEO of BioLineRx, we uncover the company's early days, its broad pipeline spanning various therapeutic areas, and the strategic decision-making process that led to its evolution. From strategic evaluations to pivoting towards oncology and hematology, this episode highlights the importance of persistence and strategic adaptability in the biotech industry.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/60277346</guid><pubDate>Wed, 05 Jun 2024 15:12:24 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/60277346/bioline_ep1_master.mp3" length="28232236" type="audio/mpeg"/><itunes:author>Industry Dive's studioID</itunes:author><itunes:subtitle>In the inaugural episode, we explore the origins of BioLineRx and its transformation from a biotech incubator to a fully-fledged biotech company. Joined by Phil Serlin, CEO of BioLineRx, we uncover the company's early days, its broad pipeline spanning...</itunes:subtitle><itunes:summary><![CDATA[In the inaugural episode, we explore the origins of BioLineRx and its transformation from a biotech incubator to a fully-fledged biotech company. Joined by Phil Serlin, CEO of BioLineRx, we uncover the company's early days, its broad pipeline spanning various therapeutic areas, and the strategic decision-making process that led to its evolution. From strategic evaluations to pivoting towards oncology and hematology, this episode highlights the importance of persistence and strategic adaptability in the biotech industry.]]></itunes:summary><itunes:duration>1176</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/000dc72cca9f80adb9a10884b302d090.jpg"/><itunes:season>1</itunes:season><itunes:episode>1</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Looking Ahead: Pipeline Development</title><link>https://www.spreaker.com/episode/looking-ahead-pipeline-development--60277394</link><description><![CDATA[Episode three of "The Power of Persistence" focuses on pipeline development in the biotech industry. Phil Serlin, CEO of BioLineRX, discusses how companies balance launching one product while maintaining pipeline development. Phil emphasizes the versatility of their platform molecule and the various applications it offers, such as stem cell mobilization for different transplantation types and gene therapy. Phil shares insights into how BioLineRX identifies potential partners and leverages existing expertise to expand their pipeline strategically. The discussion underscores the dynamic nature of the biotech industry and the need for companies to seize the moment while preparing for the future.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/60277394</guid><pubDate>Wed, 05 Jun 2024 13:41:13 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/60277394/bioline_ep3_master.mp3" length="23235410" type="audio/mpeg"/><itunes:author>Industry Dive's studioID</itunes:author><itunes:subtitle>Episode three of "The Power of Persistence" focuses on pipeline development in the biotech industry. Phil Serlin, CEO of BioLineRX, discusses how companies balance launching one product while maintaining pipeline development. Phil emphasizes the...</itunes:subtitle><itunes:summary><![CDATA[Episode three of "The Power of Persistence" focuses on pipeline development in the biotech industry. Phil Serlin, CEO of BioLineRX, discusses how companies balance launching one product while maintaining pipeline development. Phil emphasizes the versatility of their platform molecule and the various applications it offers, such as stem cell mobilization for different transplantation types and gene therapy. Phil shares insights into how BioLineRX identifies potential partners and leverages existing expertise to expand their pipeline strategically. The discussion underscores the dynamic nature of the biotech industry and the need for companies to seize the moment while preparing for the future.]]></itunes:summary><itunes:duration>968</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/000dc72cca9f80adb9a10884b302d090.jpg"/><itunes:episodeType>full</itunes:episodeType></item></channel></rss>
